Drug Delivery Devices Market

China Drug Delivery Devices Market by Route of Applications (Cardiovascular, Oncology, Autoimmune Disorder, Pulmonary Disease, and Other), Device Type (Nasal [Inhalers, and Other], Injectable [Conventional Drug Delivery Devices, and Self-injectable Drug Delivery Devices [Prefilled Syringes, Auto Injectors, and Others], Implantable, and Others), End Users (Hospitals, Pharmacy, and Others), and Country - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-3108
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 53
  • No. Of Pages: 204
  • Format:
  • Pub. Date: Upcoming
  • Share:

The China drug delivery devices market size is anticipated to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the Italy moving towards value-based healthcare and rising technological advancements, growth in the biologics market.

China Drug Delivery Devices Market Summary

Drugs at the action site cannot reach adequate concentrations to achieve predicted therapeutic outcomes due to poor physicochemical qualities and multi-stage biological barriers in vivo, which can lead to side effects in normal tissues and organs. For hundreds of years, Traditional Chinese Medicine (TCM) has been utilized in China to prevent and treat numerous ailments. The active ingredients are the are crucial active compounds that can help cure illnesses in a variety of ways. However, their low solubility, instability, and fast elimination make them ineffective. As a result, we must address these issues in order to increase the therapeutic effectiveness.

A unique medical therapy with a multi-level and multi-target strategy that is pulmonary drug delivery system (PDDS) which is intended to minimize systemic metabolism and adverse responses of the medicine and to increase drug bioavailability also it solves the present clinical issues with oral and injectable this aid traditional Chinese medicine (TCM) to rapidly gained popularity across the world. The increased incidence of chronic illnesses, technical improvements, and the expansion of the biologics industry are all projected to propel the drug delivery devices market forward throughout the forecast period.

China's population is ageing, and chronic ailments are becoming more common. Since 1970, China's population life expectancy has grown by 17 years. From 2010 to 2040, the proportion of Chinese citizens aged 60 and up is expected to rise from 12.4 percent (168 million) to 28 percent (402 million).

According to WHO, Diabetes affects over 10% of all adults in China, or around 110 million individuals. Diabetes and its consequences account for about 1 million deaths in China each year. This leads to rising demand for auto injectors and wearable injectors device demand. Recently developed technology is transdermal drug delivery has recently progressed from crude approaches that depend only on natural diffusion to dynamic drug release systems that respond to external stimuli. Microneedles have also been used to break through physical barriers in the skin, allowing for regulated distribution via wearable biosensors.

Nanoscale drug delivery systems (NDDS) have rapidly evolved in order to deliver medications to their target sites. NDDS with adjustable drug behaviors on tissues, cells, and organelles can be used to break through multi-stage barriers and manage drug metabolism, in addition to preventing drug degradation and conserving drug physicochemical qualities. 

In August 2021, Weihai Hengyu Medical Products, a Chinese injectable medicine delivery company, has agreed to sell Aptar an 80 percent ownership in the company. Even if China seeks to reduce its reliance on foreign imports, Aptar will be able to access the key market as a result of the purchase.

In July 2018 Zhejiang Yangtze River Delta Biotech Management and   IRISYS, LLC, a San Diego-based contract pharmaceutical product development and manufacturing services provider, announced to signed a memorandum of understanding with to co-build and co-run a new Drug Delivery Systems platform as part of the International Accelerator in Hangzhou, Zhejiang province, China.

Market Trends, Drivers, Restraints, and Opportunities

  • Rise in the incidence of cardiovascular illnesses (CVD), demanding the use of long-term medication.
  • Development in new generation devices such as portable and wearable are gaining popularity particularly in the home healthcare market.
  • Development of novel drug therapies is anticipated to fuel the market even further.
  • Increased awareness among population for drug are projected to boost the Italian drug delivery devices market.
  • Rising Obesity and diabetes among the urban population leading to heart related issue is the major driver for the market.
  • Simplicity, dependability, and the possibility to be administered by the patient directly are fueling the market.
  • Unaffordability, lack of or no reimbursements are anticipated to restrain the market.
  • Research and development in novel drugs and delivery system are creating a significant opportunity for market player.

Scope of the Report

The report on China drug delivery devices Market the includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

China Drug Delivery Devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Applications (Cardiovascular, Oncology, Autoimmune Disorder, Pulmonary Disease, and Other), Device Type (Nasal [Inhalers, and Other], Injectable [Conventional Drug Delivery Devices, and Self-injectable Drug Delivery Devices [Prefilled Syringes, Auto Injectors, and Others], Implantable, and Others), End Users (Hospitals, Pharmacy, and Others)

Country Scope

China

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

F. Hoffmann-La Roche AG; Becton; Dickinson and Company; Teva Pharmaceutical Industries Ltd.; Gerresheimer AG; Pfizer Inc

China Drug Delivery Devices Market Segment Insights

The cardiovascular segment is estimated to account for a major market share

Based on route of applications, China drug delivery devices market is divided into cardiovascular, oncology, autoimmune disorder, pulmonary disease, and other. The cardiovascular is expected to represent a key share of the market due to rising aging population and behavioral changes in lifestyles and stroke, pulmonary heart disease, heart failure (HF), rheumatic heart disease, congenital heart disease, coronary heart disease (CHD), and hypertension are major causes of death in the rural Chinese population.

China Drug Delivery Devices Market Application

The auto injectors segment is expected to grow at a robust pace

In terms of device type, the China drug delivery devices market is segmented into nasal, injectable, implantable, and others. The injectable segment further segregated into conventional drug delivery devices, and self-injectable drug delivery devices. The self-injectable drug delivery devices are further divided into prefilled syringes, auto injectors, and others. The auto injectors are expected to represent a key share of the market in the coming years due to research advancement and innovative designs, such as portable devices, autoinjectors with two auto injectable doses in one device are driving the market.

China Drug Delivery Devices Market Device Types

The hospitals segment is anticipated to register rapid CAGR

On the basis of end users, the China drug delivery devices market is divided into hospitals, ambulatory surgical centers, and other. The hospitals segment is expected to constitute a key share of the market during the forecast period due to increased elderly population and advancements in pharmaceutical or drug delivery technologies.

China Drug Delivery Devices Market End Users

Segments

The China drug delivery devices market has been segmented on the basis of

Applications

  • Cardiovascular
  • Oncology
  • Autoimmune Disorder
  • Pulmonary Disease
  • Other

Device Type

  • Nasal
    • Inhalers
    • Other
  • Injectable
    • Conventional Drug Delivery Devices
    • Self-injectable Drug Delivery Devices
      • Prefilled Syringes
      • Auto Injectors
      • Others
  • Implantable
  • Others

 End Users

  • Hospitals
  • Pharmacy
  • Others

Country

  • China

Key Players

  • F. Hoffmann-La Roche AG
  • Becton
  • Dickinson and Company
  • Teva Pharmaceutical Industries Ltd.
  • Gerresheimer AG
  • Pfizer Inc

Competitive Landscape

Key players competing in the China drug delivery devices market include F. Hoffmann-La Roche AG; Becton; Dickinson and Company; Teva Pharmaceutical Industries Ltd.; Gerresheimer AG; Pfizer Inc.

China Drug Delivery Devices Market Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Delivery Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Drug Delivery Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Drug Delivery Devices Market - Supply Chain
  4.5. Global Drug Delivery Devices Market Forecast
     4.5.1. Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Drug Delivery Devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Drug Delivery Devices Market Absolute $ Opportunity
5. Global Drug Delivery Devices Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Drug Delivery Devices Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Drug Delivery Devices Demand Share Forecast, 2019-2026
6. North America Drug Delivery Devices Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Drug Delivery Devices Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Drug Delivery Devices Demand Share Forecast, 2019-2026
7. Latin America Drug Delivery Devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Drug Delivery Devices Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Drug Delivery Devices Demand Share Forecast, 2019-2026
8. Europe Drug Delivery Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Drug Delivery Devices Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Drug Delivery Devices Demand Share Forecast, 2019-2026
9. Asia Pacific Drug Delivery Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Drug Delivery Devices Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Middle East & Africa Drug Delivery Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Drug Delivery Devices Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Drug Delivery Devices Market: Market Share Analysis
  11.2. Drug Delivery Devices Distributors and Customers
  11.3. Drug Delivery Devices Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. F. Hoffmann-La Roche AG
     11.4.2. Becton
     11.4.3. Dickinson and Company
     11.4.4. Teva Pharmaceutical Industries Ltd.
     11.4.5. Gerresheimer AG
     11.4.6. Pfizer Inc

The China drug delivery devices market has been segmented on the basis of

Applications

  • Cardiovascular
  • Oncology
  • Autoimmune Disorder
  • Pulmonary Disease
  • Other

Device Type

  • Nasal
    • Inhalers
    • Other
  • Injectable
    • Conventional Drug Delivery Devices
    • Self-injectable Drug Delivery Devices
      • Prefilled Syringes
      • Auto Injectors
      • Others
  • Implantable
  • Others

 End Users

  • Hospitals
  • Pharmacy
  • Others

Country

  • China

Key Players

  • F. Hoffmann-La Roche AG
  • Becton
  • Dickinson and Company
  • Teva Pharmaceutical Industries Ltd.
  • Gerresheimer AG
  • Pfizer Inc

Key players competing in the China drug delivery devices market include F. Hoffmann-La Roche AG; Becton; Dickinson and Company; Teva Pharmaceutical Industries Ltd.; Gerresheimer AG; Pfizer Inc.

China Drug Delivery Devices Market Key Players

Buy Report